Harsha Moole is an internal medicine-trained physician-scientist with more than 100 peer-reviewed publications, including work featured in the New England Journal of Medicine. After years of clinical practice and gastroenterology outcomes research, he made an unconventional transition from the bedside to the boardroom by founding PhysicianEstate, a health care-focused venture capital firm.
Over the past seven years, Dr. Moole has made 22 early-stage health care investments across digital health, medical devices, biotech, and therapeutics. He has also built a network of more than 200 physicians from institutions such as Johns Hopkins and Stanford who help source opportunities and provide clinical diligence before capital is deployed. His core thesis is that physician-scientists with firsthand clinical experience are uniquely positioned to identify health care investments that generalist investors often miss.
His research background is reflected in his publication record on Google Scholar, and he shares professional updates on LinkedIn.
I graduated residency with over 100 peer-reviewed publications, an EB-1A visa for extraordinary ability in medicine, and zero understanding of how health care capital works.
Nobody taught me what a term sheet was. Nobody explained how venture capital flowed into the companies building the devices, drugs, and software I used on patients every day. Nobody mentioned that the same analytical rigor I applied to systematic reviews, defining a question, evaluating evidence, …
Read more…
Physicians belong in health care venture capital
Nobody in my residency program would have predicted I’d end up in venture capital. Certainly not me.
I immigrated to the United States from India with a straightforward plan: become the best physician-scientist I could and build a career in academic medicine. For the first chapter of my professional life, that’s exactly what I did. I trained in internal medicine, published over 100 peer-reviewed papers including in the New England Journal …
Read more…
Physicians in venture capital see what others miss
I built an AI-powered system that sources and scouts healthcare startup companies and generates structured investment memos on them in under ten minutes. It pulls data from public filings, clinical trial registries, patent databases, and competitive landscapes. It scores companies across multiple risk dimensions. It produces fifteen-section analyses that would take a human analyst days to assemble.
I use it constantly. And I would never let it make an investment decision.
I …
Read more…
3 things AI in health care investing cannot evaluate
Every physician remembers the first time they ran a code. The adrenaline. The organized chaos. The moment you reach for the crash cart and trust, without thinking, that everything inside it is where it should be, that the medications aren’t expired, and that the equipment has been checked.
But here’s what most physicians don’t think about: Who’s making sure that crash cart is actually compliant? Who’s tracking whether every piece of …
Read more…
The crash cart that taught me physician-led investing
Most health care startups don’t fail because the technology is bad. They fail because of mistakes that happen long before the product ever reaches a clinical setting. After seven years of evaluating health care companies as a physician-scientist turned venture investor (and making over 20 investments across digital health, biotech, medical devices, and therapeutics), I’ve started to see the same patterns repeat.
These aren’t obscure business school failures. They’re patterns that …
Read more…
5 patterns behind health care startups that fail
A few months ago, a well-connected investor sent me a deal for a surgical device with a proprietary safety feature. U.S. Food and Drug Administration (FDA)-cleared. Strong intellectual property. Thousands of units sold. Multiple institutional backers across several rounds. The investor who referred it had taken a company to a NASDAQ initial public offering and was putting in his own money.
On paper, this was exactly the kind of deal most …
Read more…
Health care investing insights from a venture capital pro
Your hospital recently adopted a new piece of technology. Maybe it was an electronic health record (EHR) module. A patient monitoring upgrade. A documentation tool. A new device in the operating room (OR). Think about what happened next. Some of your colleagues embraced it. Others resisted. The nurses figured out workarounds within a week. The information technology (IT) department sent three emails about training sessions that nobody attended. Six months …
Read more…
Health care investing demands thorough clinical diligence
Last year, a startup pitched me a device designed to improve endoscopic procedures in gastroenterology. Slick deck. Strong team. Blue-chip venture capital (VC) backing. One problem: The device added three extra steps to a workflow that gastroenterologists have spent decades optimizing for speed. Any gastrointestinal (GI) physician would have flagged this in the first five minutes. But the investors who wrote the check? None of them had ever held a …
Read more…
Health care startups desperately need clinical expertise
